US Secretary of State Marco Rubio arrived in Kolkata, marking the first visit by an American secretary of state in 14 years. His four-day d...

Indian corporate profits are currently strong. However, rising input costs present a significant challenge ahead. Investors should remain p...

The AI-powered startup offers cognitive assessments measuring attention, memory, and executive function, providing users with benchmarked s...

Affluent Indians are increasingly eyeing Greece as a destination for permanent residency. The motivations behind this trend include evolvin...

Mumbai's historic Elphinstone Road Overbridge is now history. Workers dismantled the 113-year-old British-era structure on Sunday. This mar...

Metropolis will acquire a 100% stake in Core Diagnostics financing Rs 135.76 crores or 55% in cash and the rest Rs 111.07 through an equity...

The October-December quarter encompasses the tail end of the monsoon as well as winter, which brings with them ailments such as influenza a...

Metropolis Healthcare, a leading diagnostic company, displayed impressive market momentum by crossing its 200-day SMA at Rs 1368.74, with a...

So in the case of lenders, my reckoning is AI will help them do more with less expenditure on head count, allow them to provide better serv...

All political parties offer freebies now and through it an entitlement mentality has been encouraged, creating a cradle-to-grave welfare st...

Metropolis chief executive Ameera Shah and her family has initiated a formal process to sell part of the promoter stake and is understood t...

Stocks that were in focus include names like Dr Lal PathLabs, which was down more than 6 per cent, Metropolis Healthcare fell more than 9 p...

As on September 30, Metropolis operates 132 labs and 3006 collection centres. It plans to end FY22 by adding at least 25 laboratories

Restaurant chains, vital cogs in any night life culture, are raring to break the time barrier and run some of their strategic outlets till ...

The dealmaking in Metropolis coincides with IPO plans of other players, notably Dr Lal Pathlabs, SRL and Thyrocare, all of whom could list ...

Companies in talks with pathology chains.

Global diagnostic laboratories chain Metropolis Healthcare today said private equity firm Warburg Pincus will invest around 85 million doll...